[Elsevier] POS0781EFFICACY AND SAFETY OF ORAL DEUCRAVACITINIB IN PATIENTS WITH CUTANEOUS MANIFESTATIONS OF LUPUS ERYTHEMATOSUS: RESULTS FROM PAISLEY CLE, A GLOBAL, RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 TRIAL |
|
This post will be closed automatically in 2026-09-06 23:23
Reward10points
|
20
The evolving role of HER2 in gynecologic oncology and clinical trial design: A gynecologic pathologist's perspective
20
Distribution and concordance of HER2 scores in endometrial and ovarian cancer
10
Energy consumption characteristics and rooftop photovoltaic potential assessment of elevated metro station
10
Adsorption of antibiotics on different microplastics (MPs): Behavior and mechanism
30
A Randomized Controlled Trial to Compare Pain Medications in Children Undergoing Strabismus Surgery
